CONRAD HERBERT J
Insider CIK 1218815 · VRUS Director · TKMR Director · MTNB Director · CLDX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2026-06-25 | 2026-06-29 | 26,000 | — | $0 | 26,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 16,500 | — | $0 | 16,500 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2023-11-01 | 2023-11-03 | 437,244 | — | $0 | 437,244 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 11,300 | — | $0 | 11,300 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2022-11-14 | 2022-11-16 | 142,657 | — | $0 | 142,657 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2022-06-22 | 2022-07-05 | 1,358,122 | — | $0 | 4,694,566 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2022-06-22 | 2022-07-05 | 1,358,122 | — | $0 | 0 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 13,600 | — | $0 | 13,600 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2021-11-01 | 2021-11-02 | 90,882 | — | $0 | 90,882 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2021-08-04 | 2022-07-05 | 494,622 | — | $0 | 0 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2021-08-04 | 2022-07-05 | 494,622 | — | $0 | 3,336,444 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2021-07-07 | 2021-07-09 | 1,280,917 | — | $0 | 1,358,122 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2021-07-07 | 2021-07-09 | 1,280,917 | — | $0 | 2,841,822 | SEC↗ |
| MTNB Matinas BioPharma Holdings | C Conversion deriv | 2021-06-19 | 2021-06-24 | 100 | — | $0 | 0 | SEC↗ |
| MTNB Matinas BioPharma Holdings | C Conversion | 2021-06-19 | 2021-06-24 | 200,000 | — | $0 | 1,560,905 | SEC↗ |
| MTNB Matinas BioPharma Holdings | J Other | 2021-06-19 | 2021-06-24 | 40,000 | — | $0 | 1,360,905 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2021-05-20 | 2021-05-24 | 1,145,905 | — | $0 | 1,320,905 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2021-05-20 | 2021-05-24 | 1,145,905 | — | $0 | 0 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift deriv | 2021-01-13 | 2021-05-24 | 100 | $1000.00 | $100.0K | 0 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift deriv | 2021-01-13 | 2021-05-24 | 100 | $1000.00 | $100.0K | 100 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2021-01-13 | 2021-05-24 | 50,000 | — | $0 | 494,622 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2021-01-13 | 2021-05-24 | 50,000 | — | $0 | 175,000 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2020-11-02 | 2020-11-10 | 122,605 | — | $0 | 122,605 | SEC↗ |
| MTNB Matinas BioPharma Holdings | J Other | 2020-06-23 | 2020-06-24 | 30,000 | — | $0 | 544,622 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 11,000 | — | $0 | 11,000 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2020-06-04 | 2020-06-05 | 2,639,039 | — | $0 | 125,000 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2020-06-04 | 2020-06-05 | 2,639,039 | — | $0 | 2,639,039 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2020-05-13 | 2020-05-15 | 2,639,039 | — | $0 | 2,764,039 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2020-05-13 | 2020-05-15 | 2,639,039 | — | $0 | 1,145,905 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2019-12-31 | 2020-01-03 | 10,573 | — | $0 | 514,622 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2019-11-01 | 2019-11-05 | 107,416 | — | $0 | 107,416 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2019-09-30 | 2019-10-02 | 38,066 | — | $0 | 504,049 | SEC↗ |
| MTNB Matinas BioPharma Holdings | C Conversion deriv | 2019-07-29 | 2019-10-02 | 20,000 | — | $0 | 0 | SEC↗ |
| MTNB Matinas BioPharma Holdings | C Conversion | 2019-07-26 | 2019-10-02 | 200,000 | — | $0 | 397,983 | SEC↗ |
| MTNB Matinas BioPharma Holdings | J Other | 2019-07-26 | 2019-10-02 | 48,000 | — | $0 | 445,983 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2019-06-30 | 2019-07-02 | 28,005 | — | $0 | 197,983 | SEC↗ |
| MTNB Matinas BioPharma Holdings | J Other | 2019-06-21 | 2019-10-02 | 20,000 | — | $0 | 465,983 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2019-06-19 | 2019-06-20 | 4,500 | — | $0 | 4,500 | SEC↗ |
| MTNB Matinas BioPharma Holdings | P Buy | 2019-05-16 | 2019-05-20 | 25,000 | $0.96 | $24.0K | 172,959 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2019-03-31 | 2019-04-03 | 22,019 | — | $0 | 122,019 | SEC↗ |
| MTNB Matinas BioPharma Holdings | G Gift | 2019-02-08 | 2019-02-12 | 3,932,903 | — | $0 | 100,000 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2018-12-31 | 2019-01-04 | 40,337 | — | $0 | 4,032,903 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2018-11-01 | 2018-11-05 | 128,299 | — | $0 | 128,299 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2018-11-01 | 2018-11-05 | 128,299 | — | $0 | 128,299 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2018-10-01 | 2018-10-03 | 26,087 | — | $0 | 3,992,566 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2018-06-29 | 2018-07-11 | 55,300 | — | $0 | 3,966,479 | SEC↗ |
| MTNB Matinas BioPharma Holdings | P Buy deriv | 2018-06-21 | 2018-06-22 | 100 | $1000.00 | $100.0K | 100 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2018-06-19 | 2018-06-22 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 67,000 | — | $0 | 67,000 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2018-03-30 | 2018-04-02 | 31,579 | — | $0 | 3,911,179 | SEC↗ |
| MTNB Matinas BioPharma Holdings | P Buy | 2017-09-07 | 2017-09-07 | 100,000 | $1.30 | $130.0K | 3,879,600 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2017-06-21 | 2017-06-22 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2017-06-15 | 2017-06-16 | 10,000 | — | $0 | 38,500 | SEC↗ |
| MTNB Matinas BioPharma Holdings | P Buy deriv | 2016-07-29 | 2019-10-02 | 20,000 | $5.00 | $100.0K | 20,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2016-06-08 | 2016-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2016-06-08 | 2016-06-09 | 10,000 | — | $0 | 28,500 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2016-06-03 | 2016-06-07 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2015-08-12 | 2015-08-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2015-06-10 | 2015-06-11 | 10,300 | — | $0 | 10,300 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2015-06-10 | 2015-06-11 | 6,500 | — | $0 | 18,500 | SEC↗ |
| TKMR TEKMIRA PHARMACEUTICALS Co | A Award deriv | 2015-03-30 | 2015-04-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2014-06-04 | 2014-06-05 | 2,000 | — | $0 | 2,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2014-06-04 | 2014-06-05 | 2,000 | — | $0 | 12,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2013-06-19 | 2013-06-20 | 2,000 | — | $0 | 2,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2013-06-19 | 2013-06-20 | 2,000 | — | $0 | 10,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2012-06-20 | 2012-06-21 | 2,000 | — | $0 | 8,000 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 40,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 40,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 15,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 40,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | D To issuer deriv | 2012-01-12 | 2012-01-17 | 20,000 | — | $0 | 0 | SEC↗ |
| VRUS Pharmasset Inc | U Tender | 2012-01-12 | 2012-01-17 | 17,000 | $137.00 | $2.33M | 0 | SEC↗ |